✦ LIBER ✦

Insulin suppression of VLDL apo B secretion is not mediated by the LDL receptor

✍ Scribed by Doru V Chirieac; Joanne Cianci; Heidi L Collins; Janet D Sparks; Charles E Sparks

Book ID: 117052531
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 95 KB
Volume: 297
Category: Article
ISSN: 0006-291X
DOI: 10.1016/s0006-291x(02)02140-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo production of VLDL-apo-B and VLD

In vivo production of VLDL-apo-B and VLDL-triglycerides are not affected by the LDL receptor

✍ B. Teusink; A.R. Mensenkamp; K. Willems van Dijk; F. Kuipers; L.M. Havekes 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 179 KB

4P-1035 The lipoprotein lipase (LPL) med

4P-1035 The lipoprotein lipase (LPL) mediated uptake of LDL, but not of chylomicrons, is mediated by the LDL receptor in vivo

✍ Merkel, M.; Heeren, J.; Loeffler, B.; Greten, H. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Degradation of the LDL receptors by PCSK

Degradation of the LDL receptors by PCSK9 is not mediated by a secreted protein acted upon by PCSK9 extracellularly

✍ Øystein L Holla; Jamie Cameron; Knut Erik Berge; Trine Ranheim; Trond P Leren 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 506 KB

## Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) post-transcriptionally degrades the low density lipoprotein receptors (LDLR). However, it is unknown whether PCSK9 acts directly on the LDLR or if PCSK9 activates another protein that in turn causes degradation of the LDLR. ## Res

Increased apo B and small dense LDL in f

Increased apo B and small dense LDL in familial combined hyperlipidemia are not explained by the degree of insulin resistance and/or obesity

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 170 KB

The hypolipidemic action of bezafibrate

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

✍ Frits H.A.F. de Man; Femke de Beer; Arnoud van der Laarse; Hans Jansen; Jan A.Ge 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 127 KB

The hypolipidemic action of bezafibrate

The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia is mediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

✍ Frits H.A.F. de Man; Femke de Beer; Arnoud van der Laarse; Hans Jansen; Jan A.Ge 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 127 KB